Medication-Assisted Treatment for Pregnant Women: An Interdisciplinary Group Based Model

References

• American College of Obstetricians and Gynecologists. (2012). Opioid abuse, dependence and addiction in pregnancy (Committee Opinion no. 524). Washington, DC: Author.
   Google Scholar
• Binder, T., & Vavrinkiva, B. (2008). Prospective randomized comparative study of the effect of buprenorphine, methadone and heroin on the course of pregnancy, birthweight of newborns, early postpartum adaptation and the course of the neonatal abstinence syndrome (NAS) in women followed up in the outpatient department. Neuroendocrinology Letters, 29(1), 80–86.
   Google Scholar
• Brady, K. T., & Randall, C. (1999). Gender differences in substance abuse disorders. Psychiatry Clinical North America, 22(2), 241–252.
   Google Scholar
• Brady, T. M., & Ashley, O.S. (Eds.). (2005). Women in substance abuse treatment: Results from the Alcohol and Drug Services Study (DHHS Pub. No. SMA 04–3968, Analytic Series A–26). Rockville, MD: Substance Abuse and Mental Health Services Administration, Office of Applied Studies.
   Google Scholar
• Columbini, N., Elias, R., Busuttil, M., Dubuc, M., Einaudi, M.A., & Bues-Charbit, M. (2008). Hospital morphine preparation of abstinence syndrome in newborns exposed to buprenorphine or methadone. Pharmacy World Science, 30(3), 227–234.
   Google Scholar
• Center for Disease Control. (2011). Overdoses of prescription opioid pain relievers—United States, 1999–2008, Vital Signs, 60, 1487–1492.
   Google Scholar
• Center for Disease Control. (2013). Opioids drive continued increase in drug overdose deaths [Press release]. Retrieved from http://www.cdc.gov/media/releases/2013/p0220_drug_overdose_deaths.html
   Google Scholar
• Fischer, G., Ortner, R., Rohrmeister, K., Jagsch, R., Baewert, A., Langer, M., & Aschauer, H. (2006). Methadone versus buprenorphine in pregnant addicts: A double-blind, double-dummy comparison study. Addiction, 101, 275–281.
   Google Scholar
• Greenfield, S. F., Cummings, A. M., Kuper, L. E., Wigderson, S. B., & Koro-Ljungberg, M. (2013). A qualitative analysis of women's experiences in single-gender versus mixed-gender substance abuse group therapy. Substance Use & Misuse, 48, 750–760.
   Google Scholar
• Greenfield, S. F., Trucco, E. M., McHugh, R. K., Lincoln, M., & Gallop, R. J. (2007). The Women's Recovery Group Study: A stage 1 trial of women-focused group therapy for Substance use disorders vs. mixed gender group counseling. Drug Alcohol Dependence, 90(1), 39–47.
   Google Scholar
• Goler, N. C., Armstrong, M. A., Taillac, C. J., & Osejo, V. M. (2008). Substance abuse treatment linked with prenatal visits improves perinatal outcomes: a new standard. Journal of Perinatology, 28, 597–603.
   Google Scholar
• Johnson, R. E., Jones, H. E., & Fischer, G. (2003). Use of buprenorphine in pregnancy: Patient management and effects on the neonate. Drug and Alcohol Dependence, 70(Suppl), 87–101.
   Google Scholar
• Jones H, Kaltenbach K, Heil S, Stine S, Coyle M, Arria A., … Fischer G. (2010). Neonatal abstinence syndrome after methadone or buprenorphine exposure. The New England Journal of Medicine, 363(24), 2320–31.
   Google Scholar
• Jones, H., O'Grady, K., Malfi, D., & Tuten, M. (2008). Methadone maintenance vs. methadone taper during pregnancy: maternal and neonatal outcomes. American Journal of Addiction, 17, 372–386.
   Google Scholar
• Jones, H., Johnson, R., Jasinski, D., O'Grady, K., Chisholm, C., Choo, R., Crocetti, M., Dudas, R., Harrow, C., Huestis, M., Jansson, L., Lantz, M., Lester, B., & Milio, L. (2005). Buprenorphine versus methadone in the treatment of pregnant opioid-dependent patients: effects on the neonatal abstinence syndrome. Drug and Alcohol Dependence, 79, 1–10.
   Google Scholar
• Kakko, J., Gronbladh, L., Svanborg, K. D., von Wachenfeldt J., Ruck C., Rawlings B., … Heiling M. (2007). A stepped care strategy using buprenorphine and methadone versus conventional methadone maintenance in heroin dependence: A randomized controlled trial. American Journal of Psychiatry, 164, 797–803.
   Google Scholar
• Kauffman, E., Dore, M. M., & Nelson-Zlupko, L. (1995). The role of women's therapy groups in the treatment of chemical dependence. American Journal of Orthopsychiatry, 65, 355–363.
   Google Scholar
• Kominars, K., Dornheim, L., Delucia-Waack, J. L., Gerrity, D. A., Keloder, C. R., & Riva, M. T. (2004). Group approaches in subtsance asbuse treatment. In J. Delucia-Waack, D. Gerrity, C. Keloder, & M. Riva (Eds.), Handbook of group counseling and psychotherapy (pp. 563–575). Thousand Oaks, CA: Sage Publications.
   Google Scholar
• Koos, E., Brand, M., Rojas, J., & Li, J. (2014). Sex-specific substance abuse treastment for female healthcare professionals: implications. Southern Medical Journal, 107, 28–33.
   Google Scholar
• Kuo, C., Chonbrun, Y., C., Zlontnick, C., Bates, N., Todorova, R., Kao, J., C., Johnson, J. (2013). A qualitative study of treatment needs among pregnant and post partum women with substance use and depression. Subtance Use Misuse, 48(14), 1498–1508.
   Google Scholar
• Lander, L., Gurka, K., Marshalek, P., Riffon, M., & Sullivan, R. (2015). A comparison of pregnancy-only vs. mixed-gender group therapy among pregnant women with opioid use disorder. Social Work Research, 39, 235–244. doi:10.1093/swr/svv029
   Google Scholar
• Lejeune, C., Simmat-Durand, L., Gourarier, L., & Aubisson, S. (2006). Prospective multicenter observational study of 260 infants born to 259 opioid-dependenct mothers on methadone or high-dose buprenorphine substitution. Drug and Alcohol Dependence, 82, 250–257.
   Google Scholar
• Livingston, J. D., Mile, T., Fang, M. L., & Amaria, E. (2011). The effectiveness of interventions for reducing stigma related to substance use disorders: A systematic review. Addiction, 107(1), 39–50.
   Google Scholar
• Metz, V., Kochl, B., & Fischer, G. (2012). Should pregnant women with substance used disorder be managed differently. Neuropsychiatry (London), 2(1), 29–41.
   Google Scholar
• Meyer, M., Johnston, A., Crocker, A., & Heil, S. (2015). Methadone and Buprenorphine of opioid dependence during pregnancy: a retrospective cohort study. Journal of Addiction Medicine, 9(2), 81–86.
   Google Scholar
• Montgomery, D. P., Plate, C. A., Jones, M., Jones, J., Rios, R., Lambert, D. K., … Christensen, R. D. (2008). Using umbilical cord tissue to detect fetal exposure to illicit drugs: a multicentered study in Utah and New Jersey. Journal of Perinatology, 28, 750–753.
   Google Scholar
• Patrick, S. W., Schumacher, R. E., Benneyworth, B. D., Krans, E. E., McAllister, J. M., & Davis, M. M. (2012). Neonatal abstinence syndrome and associated health care expenditures United States, 2000–2009. JAMA: Journal of the American Medical Association, 307, 1934–1940.
   Google Scholar
• Prendergast, M. L., Messina, N. P., Hall, E. A., & Warda, U. S. (2011). The relative effectiveness of women-only and mixed-gender treatment for substance-abusing women. Journal of Substance Abuse Treatment, 40, 336–348.
   Google Scholar
• Shand, F. L., Degenhardt, L., Slade, T., & Nelson, E. C. (2011). Sex differences amongst dependent heroin users: histories, clinical characteristics and predictors of other substance dependence. Addict Behavior, 36(1–2), 27–36.
   Google Scholar
• Stabler, M. E., Long, D. L., Chertok, I., Giacobbi, P. R., Pilkerton, C., & Laura, L. (2016). Neonatal abstinence syndrome in West Virginia sub-state regions, 2007–2013. The Journal of Rural Health, 00, 1–10. doi:10.1111/jrh.12174. PMID: 26879950
   PubMedGoogle Scholar
• Stitely, M. L., Calhoun, B., Maxwell, S., Nerhood, R., & Chaffin, D. (2010). Prevalence of drug use in pregnant West Virginia patients. The West Virginia Medical Journal, 106(4), 48.
   Google Scholar
• Substance Abuse and Mental Health Services Administration. (2014). Results from the 2013 National Survey on Drug Use and Health: Summary of national findings (NSDUH Series H-48, HHS Publication No. (SMA)14-4863). Rockville, MD: Substance Abuse and Mental Health Services Administration. Retrieved from http://www.samhsa.gov/data/NSDUH/2013SummNatFindDetTables/Index.aspx; http://www.samhsa.gov/data/NSDUH/2013SummNatFindDetTables/NationalFindin
   Google Scholar
• Substance Abuse and Mental Health Services Administration/Center for Substance Abuse Treatment. (2005). Substance abuse treatment: Group therapy (Treatment Improvement Protocol Series, No. 41). Rockville, MD: Author.
   Google Scholar
• Substance Abuse and Mental Health Services Administration/Center for Substance Abuse Treatment. (2008). Medication assisted treatment for opioid addiction during pregnancy (Treatment Improvement Protocols Series). Rockville, MD: Author.
   Google Scholar
• Unger, A., Jung, E., Winklbaur, B., & Fischer, G. (2010). Gender issues in the pharmacotherapy of Opioid addicted women: buprenorphine. Jounral of Addictive Diseases, 29(2), 217–230.
   Google Scholar
• Yalom, I., & Leszcz, M. (2005). The theory and practice of group psychotherapy (5th ed.). Cambridge MA: Basic Books.
   Google Scholar
• Zheng, W., Lander, L., Wen, S., Xiao, M., Marshalek, P., Nickasch, M., Dix, E., & Sullivan, C. (2016). Treatment outcome comparison between face-to-face and telepsychiatry medication-assisted treatment (MAT) buprenorphine for opioid use disorder: a 2-year retrospective data analysis. Unpublished manuscript.
   Google Scholar